Pay in 4 interest-free payments of $5.09 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
A Novel Mechanism Driving Poor-Prognosis Prostate Cancer: Overexpression of the DNA Repair Gene, Ribonucleotide Reductase Small Subunit M2 (RRM2)
Gyurk, K
Resource Centers are a selected collection of activities all connected to the same theme
*JAMA Internal Medicine*, 173(5), 386-388
[9] [10] For patients with established cardiovascular disease, SGLT2 inhibitors are generally prioritised for cardiorenal protection, with GLP-1 receptor agonists with proven cardiovascular benefit considered when SGLT2 inhibitors are unsuitable
US$ 20.20
US$ 20.12
US$ 25.39
US$ 20.11
US$ 24.93
US$ 24.02
US$ 20.69
